LIVE

Serial Number

97187987

Owner

ROME Therapeutics, Inc.

Attorney

Glenn A. Gundersen

Filing Date

Dec 23, 2021

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

ROME THERAPEUTICS Trademark

Serial Number: 97187987

ROME THERAPEUTICS is a trademark filed by ROME Therapeutics, Inc. on December 23, 2021. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Owner Contact Info

ROME Therapeutics, Inc. (5 trademarks)

201 Brookline Ave., Suite 1001
Boston, MA 02215

Entity Type: 03

Legal Representation

Attorney of Record

Glenn A. Gundersen

3,080 trademarks filed View all →

Correspondence Address

Glenn A. Gundersen DECHERT LLP

2929 ARCH STREET, CIRA CENTRE

PHILADELPHIA, PA 19104-2808

United States

Trademark Details

Filing Date

December 23, 2021

Registration Date

Not Registered

Published for Opposition

November 29, 2022

Goods & Services

Pharmaceutical preparations for the treatment of oncology, autoimmune, neurodegenerative, and other related diseases; veterinary preparations for the treatment of oncology, autoimmune, neurodegenerative, and other related diseases

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Nov 13, 2025 EXRA

SOU EXTENSION 5 GRANTED

Nov 12, 2025 EX5G

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Nov 12, 2025 AITU

SOU EXTENSION 5 FILED

Jul 23, 2025 EXT5

SOU TEAS EXTENSION RECEIVED

Jul 23, 2025 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Mar 4, 2025 EXRA

SOU EXTENSION 4 GRANTED

Jan 25, 2025 EX4G

SOU EXTENSION 4 FILED

Jan 24, 2025 EXT4

SOU TEAS EXTENSION RECEIVED

Jan 24, 2025 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Jul 18, 2024 EXRA

SOU EXTENSION 3 GRANTED

Jul 18, 2024 EX3G

SOU EXTENSION 3 FILED

Jul 18, 2024 EXT3

SOU TEAS EXTENSION RECEIVED

Jul 18, 2024 EEXT

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

Mar 11, 2024 CHAN

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Mar 11, 2024 AITU

TEAS POST PUBLICATION AMENDMENT RECEIVED

Jan 26, 2024 EPPA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Jan 25, 2024 EXRA

SOU EXTENSION 2 GRANTED

Jan 23, 2024 EX2G

SOU EXTENSION 2 FILED

Jan 23, 2024 EXT2

SOU TEAS EXTENSION RECEIVED

Jan 23, 2024 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Jun 28, 2023 EXRA

SOU EXTENSION 1 GRANTED

Jun 26, 2023 EX1G

SOU EXTENSION 1 FILED

Jun 26, 2023 EXT1

SOU TEAS EXTENSION RECEIVED

Jun 26, 2023 EEXT

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Jan 24, 2023 NOAM

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Nov 29, 2022 NPUB

PUBLISHED FOR OPPOSITION

Nov 29, 2022 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Nov 9, 2022 NONP

APPROVED FOR PUB - PRINCIPAL REGISTER

Oct 21, 2022 CNSA

EXAMINER'S AMENDMENT ENTERED

Oct 18, 2022 XAEC

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Oct 18, 2022 GNEN

EXAMINERS AMENDMENT E-MAILED

Oct 18, 2022 GNEA

EXAMINERS AMENDMENT -WRITTEN

Oct 18, 2022 CNEA

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Oct 13, 2022 GNRN

NON-FINAL ACTION E-MAILED

Oct 13, 2022 GNRT

NON-FINAL ACTION WRITTEN

Oct 13, 2022 CNRT

ASSIGNED TO EXAMINER

Sep 27, 2022 DOCK

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Dec 30, 2021 NWOS

NEW APPLICATION ENTERED

Dec 27, 2021 NWAP

Related Trademarks

More from this Owner

ROME THERAPEUTICS

More in Same Class

GEN8

Serial #79336268